At the time of writing, Alto Neuroscience Inc [ANRO] stock is trading at $17.1, up 0.41%. An important factor to consider is whether the stock is rising or falling in short-term value. The ANRO shares have gain 29.06% over the last week, with a monthly amount glided 41.21%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Previously, Chardan Capital Markets started tracking the stock with Buy rating on September 29, 2025, and set its price target to $15. On October 23, 2024, downgrade downgraded it’s rating to Neutral and revised its price target to $4 on the stock. Rodman & Renshaw downgraded its rating to a Neutral. Wedbush initiated its recommendation with an Outperform and recommended $29 as its price target on September 03, 2024. In a note dated February 27, 2024, TD Cowen initiated an Outperform rating.
For the past year, the stock price of Alto Neuroscience Inc fluctuated between $1.60 and $17.60. Currently, Wall Street analysts expect the stock to reach $16 within the next 12 months. Alto Neuroscience Inc [NYSE: ANRO] shares were valued at $17.1 at the most recent close of the market. An investor can expect a potential drop of -6.43% based on the average ANRO price forecast.
Analyzing the ANRO fundamentals
Gross Profit Margin for this corporation currently stands at -0.7% with Operating Profit Margin at -178.28%, Pretax Profit Margin comes in at -164.62%, and Net Profit Margin reading is -164.62%. To continue investigating profitability, this company’s Return on Assets is posted at -0.41, Equity is -0.45 and Total Capital is -0.47. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.03.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 16.11 points at the first support level, and at 15.11 for the second support level. However, for the 1st resistance point, the stock is sitting at 17.89, and for the 2nd resistance point, it is at 18.67.
Ratios To Look Out For
It is important to note that Alto Neuroscience Inc [NYSE:ANRO] has a current ratio of 15.42. On the other hand, the Quick Ratio is 15.42, and the Cash Ratio is 18.16.
